ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618757; 2) Community: the network communities that were significantly associated with the response to NSC 618757; 3) Molecule: the relationships between components within communities and NSC 618757; 4) MDR: the compounds that were significantly associated with the NSC 618757.

NSC Compound Enrichment Correlation
NSC 711737 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazole-2,7(1H)-dione, 4,6-dichloro-3a,7a-dihydro-, CIS- 0.00359493104490023 0.25635819
NSC 717571 Null 0.00359493104490023 0.25133609
NSC 720296 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-methyl)cyclohexane 0.00359493104490023 0.24007779
NSC 720719 Null 0.00359493104490023 0.4079887
NSC 721084 Null 0.00359493104490023 0.55366716
NSC 733008 Null 0.00359493104490023 0.28688726
NSC 737077 Null 0.00359493104490023 0.28606526
NSC 748146 5-bromo-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.00359493104490023 0.29670156
NSC 87500 Solacongestidine 0.00359493104490023 0.4208685
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.00366577979610621 0.44586839
Total:91  Current:12    [First] [Prev] [Next] [Last]